Petrini, S.; Righi, C.; Mészáros, I.; D’Errico, F.; Tamás, V.; Pela, M.; Olasz, F.; Gallardo, C.; Fernandez-Pinero, J.; Göltl, E.;
et al. The Production of Recombinant African Swine Fever Virus Lv17/WB/Rie1 Strains and Their In Vitro and In Vivo Characterizations. Vaccines 2023, 11, 1860.
https://doi.org/10.3390/vaccines11121860
AMA Style
Petrini S, Righi C, Mészáros I, D’Errico F, Tamás V, Pela M, Olasz F, Gallardo C, Fernandez-Pinero J, Göltl E,
et al. The Production of Recombinant African Swine Fever Virus Lv17/WB/Rie1 Strains and Their In Vitro and In Vivo Characterizations. Vaccines. 2023; 11(12):1860.
https://doi.org/10.3390/vaccines11121860
Chicago/Turabian Style
Petrini, Stefano, Cecilia Righi, István Mészáros, Federica D’Errico, Vivien Tamás, Michela Pela, Ferenc Olasz, Carmina Gallardo, Jovita Fernandez-Pinero, Eszter Göltl,
and et al. 2023. "The Production of Recombinant African Swine Fever Virus Lv17/WB/Rie1 Strains and Their In Vitro and In Vivo Characterizations" Vaccines 11, no. 12: 1860.
https://doi.org/10.3390/vaccines11121860
APA Style
Petrini, S., Righi, C., Mészáros, I., D’Errico, F., Tamás, V., Pela, M., Olasz, F., Gallardo, C., Fernandez-Pinero, J., Göltl, E., Magyar, T., Feliziani, F., & Zádori, Z.
(2023). The Production of Recombinant African Swine Fever Virus Lv17/WB/Rie1 Strains and Their In Vitro and In Vivo Characterizations. Vaccines, 11(12), 1860.
https://doi.org/10.3390/vaccines11121860